Conference and Professional Development Grant recipient: Paula Cronin

11 October 2013
TCRN CPD Grant Recipient; Paula Cronin, CHERE

Paula Cronin is a research officer at the Centre for Health Economics Research and Evaluation (CHERE) at the University of Technology, Sydney. Her research is focused on modelling the cost efficacy of a range of health care initiatives, such as cancer screening programs, clinical trials and the addition of new drugs to the Pharmaceutical Benefits Scheme (PBS).

A member of the TCRN, Cronin recently received a TCRN Conference and Professional Development Travel Grant to attend the International Society for Pharmaeconomics and Outcomes Research in New Orleans.

“The conference was based in the USA, where the HTA process is quite different.  In Australia HTA assessments are undertaken largely as government contracts.  This means that often you’re bound by commercial-in-confidence agreements , which limits your ability to publish,” Cronin says.  

“In the USA, the structure of the HTA process allows greater accessibility to the latest HTA methodology and results.”

Attending the conference has given Cronin new insights into her own working practices, and inspiration for how she might approach future projects.

“They had fantastic poster sessions, particularly on cancer treatments, which provided a great insight as to the way that researchers had handled data and the methodology around analysing data,” she says.

“For your next project, you’re always looking at, ‘How am I going to answer this question? How am I going to clean the data and use it in the best way I can? What modelling technique will I use to make sure that I can measure the outcomes of interest?

“I guess I just always want to improve on and increase my knowledge and improve on the methods that I use and the way that I analyse data.”

Cronin’s membership with the TCRN springs from an ongoing association between the TCRN and CHERE. Both organisations provide support services for a major cancer clinical trials initiative called the Cancer Research Economics Support Team (CREST), assisting with the development of cancer clinical trials protocols and the incorporation of health economics into new trial systems. 

“The TCRN has been fantastic because it has opened new opportunities, specifically focusing on cancer, which we have not had access to before. The travel grants mean that international conferences that were out of reach beforehand are now accessible.”

Grant snapshot

Conference: ISPOR 18th Annual International Meeting
Location: New Orleans, USA
Objective: Conference attendee